← Leaderboards
Keqi Tang
Battelle Pacific Northwest Laboratories
$2,229,275
Attributed
$2,524,679
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $672K · FY2011–16$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$2,524,679 · 3
By mechanism
R33$1,327,326 · 1
R21$1,197,353 · 2
Top collaborators
- Qibin Zhang3 shared
Most similar at Battelle Pacific Northwest Laboratories
Same institution · by research overlap
- Richard D Smith$52,400,845
- Erin S Baker$6,247,283
- Yehia Ibrahim$4,750,347
- Ryan T Kelly$7,962,804
- Tao Liu$8,021,664
Others in their field
Top investigators on “Mass Spectrum Analysis”
- Paul S. Aisen · Cognition Therapeutics, Inc.$30,310,037
- Reisa A. Sperling · Banner Health$30,310,037
- Richard D Smith · Battelle Pacific Northwest Laboratories$28,842,237
- Ronald C Petersen · Mayo Clinic Coll Of Medicine, Rochester$28,666,849
- David Heimbrook · Leidos Biomedical Research, Inc.$27,692,696
- John Robert Yates · Scripps Research Institute, The$26,948,886
Research focus
Mass Spectrum AnalysisBaseLaboratoriesInstrumentHigh Pressure Liquid ChromatographyPacific NorthwestTechnologyComplexIonsMalignant NeoplasmsSamplingMeasurementPerformanceCoupledNano-ElectrosprayPlasmaCommunicable DiseasesIsomerismPressureInsightIonizationDiabetes MellitusIon MobilityMass Spectrometer
Grant awards (8)
A hybrid IMS-MS platform for ultrasensitive and high resolution glycan analysis$303,272
R21 · FY2016 · CA · contact PI
A hybrid IMS-MS platform for ultrasensitive and high resolution glycan analysis$303,272
R21 · FY2015 · CA · contact PI
An Ultrasensitive Mass Spectrometry Platform for Comprehensive Analysis of Lipids$173,719
R21 · FY2014 · GM
Validation and Advanced Development of Emerging Technologies$408,071
R33 · FY2013 · CA · contact PI
An Ultrasensitive Mass Spectrometry Platform for Comprehensive Analysis of Lipids$199,626
R21 · FY2013 · GM
Validation and Advanced Development of Emerging Technologies$454,531
R33 · FY2012 · CA · contact PI
An Ultrasensitive Mass Spectrometry Platform for Comprehensive Analysis of Lipids$217,464
R21 · FY2012 · GM
Validation and Advanced Development of Emerging Technologies$464,724
R33 · FY2011 · CA · contact PI